Breakfast breakthrough? study tests if food can improve kidney cancer drug tolerability
Disease control
Completed
This study looked at whether taking the kidney cancer drug cabozantinib with a light breakfast changes how much drug gets into the body. Twelve patients with advanced kidney cancer took the drug both on an empty stomach and with a light breakfast, and researchers measured drug le…
Phase: PHASE2 • Sponsor: dr. Tom van der Hulle • Aim: Disease control
Last updated Jun 26, 2026 13:02 UTC